Cargando…
A bivalent live-attenuated vaccine candidate elicits protective immunity against human adenovirus types 4 and 7
Human adenovirus types 4 (HAdV4) and 7 (HAdV7) often lead to severe respiratory diseases and occur epidemically in children, adults, immune deficiency patients, and other groups, leading to mild or severe symptoms and even death. However, no licensed adenovirus vaccine has been approved in the marke...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477930/ https://www.ncbi.nlm.nih.gov/pubmed/34520320 http://dx.doi.org/10.1080/22221751.2021.1981157 |